
Shares of infusion therapy services provider Option Care Health OPCH.O rise 2.03% to $33.3 premarket
Co forecasts 2025 revenue in the range of $5.3 bln to $5.5 bln and profit between $1.59 to $1.69/share, higher than analysts' estimate of $5.26 bln and $1.25/share, respectively, as per data compiled by LSEG
Co posts Q4 revenue of $1.35 bln, beating analyst estimates of $1.29 bln
Co reports Q4 profit of 35 cents/share, vs analyst est of 34 cents/share
Stock has risen 4.3% in the past 12 months